6-33178309-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP2
The NM_080680.3(COL11A2):āc.1817C>Gā(p.Ser606Trp) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000267 in 1,612,394 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S606L) has been classified as Likely benign.
Frequency
Consequence
NM_080680.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COL11A2 | NM_080680.3 | c.1817C>G | p.Ser606Trp | missense_variant, splice_region_variant | 20/66 | ENST00000341947.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COL11A2 | ENST00000341947.7 | c.1817C>G | p.Ser606Trp | missense_variant, splice_region_variant | 20/66 | 5 | NM_080680.3 | P4 | |
COL11A2 | ENST00000374708.8 | c.1559C>G | p.Ser520Trp | missense_variant, splice_region_variant | 18/64 | 5 | A1 | ||
COL11A2 | ENST00000361917.6 | c.446C>G | p.Ser149Trp | missense_variant, splice_region_variant | 8/24 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151614Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000203 AC: 5AN: 246588Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134400
GnomAD4 exome AF: 0.0000288 AC: 42AN: 1460780Hom.: 0 Cov.: 35 AF XY: 0.0000372 AC XY: 27AN XY: 726706
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151614Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74024
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2022 | Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jul 19, 2022 | This sequence change replaces serine, which is neutral and polar, with tryptophan, which is neutral and slightly polar, at codon 606 of the COL11A2 protein (p.Ser606Trp). This variant is present in population databases (rs147328015, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with COL11A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 179481). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 13, 2014 | The Ser606Trp variant in COL11A2 has not been previously reported in individuals with hearing loss or in large population studies. Computational analyses (bioch emical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do n ot provide strong support for or against an impact to the protein. In summary, a dditional information is needed to fully assess the clinical significance of thi s variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at